Methadone Maintenance and Other Pharmacotherapeutic Interventions in the Treatment of Opioid Dependence. Overview Drug Courts are being confronted with increasing numbers of opiate dependent offenders. This Fact Sheet is intended to dispel misperceptions and educate practitioners about the efficacy of medication assisted treatment. Opioid dependence is a devastating reality and a treatable disease. According to…

J Psychoactive Drugs 1999 Apr-Jun;31(2):95-102 Maxwell S, Shinderman M Center for Addictive Problems Chicago, Illinois  60610 Using signs, symptoms and serum methadone levels to guide evaluation, the authors treated 164 patients in a methadone maintenance program with doses of methadone exceeding 100 mg/d. The mean dose of these higher dose (HD) patients was 211 mg/d…

[Federal Register: January 17, 2001 (Volume 66, Number 11)] [Rules and Regulations] [Page 4075-4102] From the Federal Register Online via GPO Access [wais.access.gpo.gov] [DOCID:fr17ja01-9]   [[Page 4075]]   ———————————————————————–   Part II   Department of Health and Human Services   ———————————————————————–   Substance Abuse and Mental Health Services Administration   ———————————————————————–   21 CFR Part…

Policy Statement Number 3 May 1994 It must be emphasized that methadone maintenance treatment is a medical treatment for narcotic addiction. Recent research has found that abstinent former heroin users have irregularities within their immune and endocrine systems. However, these irregularities are normalized with methadone maintenance. This further underscores that methadone maintenance is a medical…

Methadone Advocacy: The Time Has Come There are many approaches that a methadone advocacy organization can utilize to bring about change. TexNAMA’s primary objective (as part of NAMA) is the empowerment of patients. By confronting the negative stereotypes TexNAMA works to end the stigma and discrimination that has made recovery and reintegration back into society…

Page One  Page Two  Page Three  Page Four  Page Five  Page Six  Page Seven  NAMA Advocate Index